CD40/CD40L expression correlates with the survival of patients with glioblastomas and an augmentation in CD40 signaling enhances the efficacy of vaccinations against glioma models

BACKGROUND: The prognosis of glioblastoma (GBM) remains poor; therefore, effective therapeutic strategies need to be developed. CD40 is a costimulatory molecule whose agonistic antibody has been shown to activate antitumor effects. Recently, CD40 has been extensively targeted for immunotherapeutic p...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Neuro Oncol
Asıl Yazarlar: Chonan, Masashi, Saito, Ryuta, Shoji, Takuhiro, Shibahara, Ichiyo, Kanamori, Masayuki, Sonoda, Yukihiko, Watanabe, Mika, Kikuchi, Toshiaki, Ishii, Naoto, Tominaga, Teiji
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2015
Konular:
Basic and Translational Investigations
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4648302/
https://ncbi.nlm.nih.gov/pubmed/26008605
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nov090
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller